Healthcare provider profile · identity verified

Amber Dawn Sexton, DO

Family Practice · SANDY HOOK, KY · NPI 1013412329

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Omeprazole	Omeprazole	498	101
Lisinopril	Lisinopril	432	109
Atorvastatin Calcium	Atorvastatin Calcium	394	94
Montelukast Sodium	Montelukast Sodium	358	66
Amlodipine Besylate	Amlodipine Besylate	334	69
Levothyroxine Sodium	Levothyroxine Sodium	333	70
Fluticasone Propionate	Fluticasone Propionate	296	77
Albuterol Sulfate Hfa	Albuterol Sulfate	275	77
Gabapentin	Gabapentin	265	59
Metformin Hcl	Metformin Hcl	254	61
Furosemide	Furosemide	229	44
Duloxetine Hcl	Duloxetine Hcl	217	38
Pantoprazole Sodium	Pantoprazole Sodium	209	48
Hydrochlorothiazide	Hydrochlorothiazide	203	48
Rosuvastatin Calcium	Rosuvastatin Calcium	198	43
Losartan Potassium	Losartan Potassium	190	45
Jardiance	Empagliflozin	189	39
Citalopram Hbr	Citalopram Hydrobromide	187	36
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	184	46
Metoprolol Tartrate	Metoprolol Tartrate	183	37
Glipizide Er	Glipizide	156	29
Metoprolol Succinate	Metoprolol Succinate	148	37
Potassium Chloride	Potassium Chloride	146	27
Sertraline Hcl	Sertraline Hcl	145	22
Tamsulosin Hcl	Tamsulosin Hcl	143	33
Metformin Hcl Er	Metformin Hcl	142	35
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	141	34
Amitriptyline Hcl	Amitriptyline Hcl	137	25
Famotidine	Famotidine	136	35
Diclofenac Sodium	Diclofenac Sodium	123	24
Carvedilol	Carvedilol	117	25
Trazodone Hcl	Trazodone Hcl	113	26
Celecoxib	Celecoxib	110	21
Meloxicam	Meloxicam	110	22
Clopidogrel	Clopidogrel Bisulfate	106	24
Ozempic	Semaglutide	105	22
Alprazolam	Alprazolam	104	16
Pravastatin Sodium	Pravastatin Sodium	101	21
Prednisone	Prednisone	101	59
Isosorbide Mononitrate Er	Isosorbide Mononitrate	99	14
Januvia	Sitagliptin Phosphate	95	22
Buspirone Hcl	Buspirone Hcl	90	16
Hydroxyzine Hcl	Hydroxyzine Hcl	90	25
Eliquis	Apixaban	86	17
Pregabalin	Pregabalin	84	15
Atenolol	Atenolol	83	17
Ibuprofen	Ibuprofen	83	23
Tizanidine Hcl	Tizanidine Hcl	83	14
Simvastatin	Simvastatin	75	20
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	73	18
Escitalopram Oxalate	Escitalopram Oxalate	72	19
Alendronate Sodium	Alendronate Sodium	70	13
Nystatin	Nystatin	68	20
Fluoxetine Hcl	Fluoxetine Hcl	67	12
Ezetimibe	Ezetimibe	65	13
Methocarbamol	Methocarbamol	65	19
Trulicity	Dulaglutide	65	suppressed
Mirtazapine	Mirtazapine	61	16
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	61	19
Nitroglycerin	Nitroglycerin	60	20
Tramadol Hcl	Tramadol Hcl	60	12
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	57	48
Tradjenta	Linagliptin	55	suppressed
Ventolin Hfa	Albuterol Sulfate	55	17
Glipizide	Glipizide	53	15
Paroxetine Hcl	Paroxetine Hcl	52	suppressed
Ropinirole Hcl	Ropinirole Hcl	52	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	50	16
Ondansetron Odt	Ondansetron	49	25
Allopurinol	Allopurinol	45	14
Fenofibrate	Fenofibrate Nanocrystallized	45	11
Spironolactone	Spironolactone	45	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	44	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	44	11
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	44	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	44	12
Azithromycin	Azithromycin	43	42
Pioglitazone Hcl	Pioglitazone Hcl	43	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	42	11
Bumetanide	Bumetanide	41	suppressed
Ipratropium Bromide	Ipratropium Bromide	41	suppressed
Mounjaro	Tirzepatide	41	11
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	41	14
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	40	suppressed
Glimepiride	Glimepiride	39	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	39	suppressed
Lamotrigine	Lamotrigine	37	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	37	13
Bupropion Xl	Bupropion Hcl	36	11
Chlorthalidone	Chlorthalidone	36	suppressed
Lovastatin	Lovastatin	36	suppressed
Spiriva Handihaler	Tiotropium Bromide	36	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	35	12
Sucralfate	Sucralfate	35	suppressed
Levetiracetam	Levetiracetam	34	suppressed
Valacyclovir	Valacyclovir Hcl	34	suppressed
Dexlansoprazole Dr	Dexlansoprazole	33	suppressed
Promethazine Hcl	Promethazine Hcl	32	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	31	suppressed
Levemir Flexpen	Insulin Detemir	31	suppressed
Meclizine Hcl	Meclizine Hcl	29	suppressed
Warfarin Sodium	Warfarin Sodium	29	suppressed
Memantine Hcl	Memantine Hcl	26	suppressed
Fluconazole	Fluconazole	25	21
Labetalol Hcl	Labetalol Hcl	25	suppressed
Risperidone	Risperidone	25	suppressed
Colchicine	Colchicine	24	suppressed
Humalog Kwikpen U-100	Insulin Lispro	24	suppressed
Lansoprazole	Lansoprazole	24	suppressed
Xarelto	Rivaroxaban	24	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Linzess	Linaclotide	22	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	22	suppressed
Propranolol Hcl	Propranolol Hcl	22	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	22	suppressed
Breo Ellipta	Fluticasone/Vilanterol	21	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	21	20
Combivent Respimat	Ipratropium/Albuterol Sulfate	20	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	20	suppressed
Hydralazine Hcl	Hydralazine Hcl	20	suppressed
Synthroid	Levothyroxine Sodium	20	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	20	suppressed
Clonidine Hcl	Clonidine Hcl	19	suppressed
Finasteride	Finasteride	19	suppressed
Novolin R	Insulin Regular, Human	19	suppressed
Verapamil Er	Verapamil Hcl	19	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	18	suppressed
Naproxen	Naproxen	18	suppressed
Amoxicillin	Amoxicillin	17	17
Diazepam	Diazepam	17	suppressed
Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	17	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	17	suppressed
Primidone	Primidone	17	suppressed
Symbicort	Budesonide/Formoterol Fumarate	17	suppressed
Terazosin Hcl	Terazosin Hcl	17	suppressed
Ulticare Pen Needle	Pen Needle, Diabetic	17	suppressed
Cefdinir	Cefdinir	16	15
Farxiga	Dapagliflozin Propanediol	16	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	16	suppressed
Ketoconazole	Ketoconazole	16	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	16	11
Valsartan	Valsartan	16	suppressed
Lidocaine Hcl Viscous	Lidocaine Hcl	15	suppressed
Myrbetriq	Mirabegron	15	suppressed
Azelastine Hcl	Azelastine Hcl	14	suppressed
Bydureon Bcise	Exenatide Microspheres	14	suppressed
Lorazepam	Lorazepam	14	suppressed
Nyamyc	Nystatin	14	suppressed
Olanzapine	Olanzapine	14	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	14	suppressed
Amiodarone Hcl	Amiodarone Hcl	13	suppressed
Bupropion Hcl Sr	Bupropion Hcl	13	suppressed
Entresto	Sacubitril/Valsartan	13	suppressed
Fenofibrate	Fenofibrate	13	suppressed
Lubiprostone	Lubiprostone	13	suppressed
Nifedipine Er	Nifedipine	13	suppressed
Testosterone Cypionate	Testosterone Cypionate	13	suppressed
Verapamil Sr	Verapamil Hcl	13	suppressed
Donepezil Hcl	Donepezil Hcl	12	suppressed
Imipramine Hcl	Imipramine Hcl	12	suppressed
Loperamide	Loperamide Hcl	12	suppressed
Topiramate	Topiramate	12	suppressed
Victoza 3-Pak	Liraglutide	12	suppressed
Acyclovir	Acyclovir	11	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	11	suppressed
Aripiprazole	Aripiprazole	11	suppressed
Clobetasol Propionate	Clobetasol Propionate	11	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	11	suppressed
Theophylline Er	Theophylline Anhydrous	11	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error